These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12511536

  • 1. Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts.
    Piuhola J, Szokodi I, Kinnunen P, Ilves M, deChâtel R, Vuolteenaho O, Ruskoaho H.
    Hypertension; 2003 Jan; 41(1):93-8. PubMed ID: 12511536
    [Abstract] [Full Text] [Related]

  • 2. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
    Magga J, Vuolteenaho O, Marttila M, Ruskoaho H.
    Circulation; 1997 Nov 04; 96(9):3053-62. PubMed ID: 9386175
    [Abstract] [Full Text] [Related]

  • 3. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
    Yamamoto K, Masuyama T, Sakata Y, Mano T, Nishikawa N, Kondo H, Akehi N, Kuzuya T, Miwa T, Hori M.
    Cardiovasc Res; 2000 Aug 04; 47(2):274-83. PubMed ID: 10946064
    [Abstract] [Full Text] [Related]

  • 4. Endothelin-1 and angiotensin II contribute to BNP but not c-fos gene expression response to elevated load in isolated mice hearts.
    Piuhola J, Szokodi I, Ruskoaho H.
    Biochim Biophys Acta; 2007 Mar 04; 1772(3):338-44. PubMed ID: 17188849
    [Abstract] [Full Text] [Related]

  • 5. Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms.
    Rossi GP, Sacchetto A, Rizzoni D, Bova S, Porteri E, Mazzocchi G, Belloni AS, Bahcelioglu M, Nussdorfer GG, Pessina AC.
    Arterioscler Thromb Vasc Biol; 2000 Apr 04; 20(4):949-56. PubMed ID: 10764658
    [Abstract] [Full Text] [Related]

  • 6. Dual role of endothelin-1 via ETA and ETB receptors in regulation of cardiac contractile function in mice.
    Piuhola J, Mäkinen M, Szokodi I, Ruskoaho H.
    Am J Physiol Heart Circ Physiol; 2003 Jul 04; 285(1):H112-8. PubMed ID: 12609819
    [Abstract] [Full Text] [Related]

  • 7. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J, Hildenbrand U, Schlegel WP, Hempel P, Nissen E, Krause EG, Bartel S.
    Arch Mal Coeur Vaiss; 2000 Aug 04; 93(8):993-6. PubMed ID: 10989744
    [Abstract] [Full Text] [Related]

  • 8. Regulation of cardiac melusin gene expression by hypertrophic stimuli in the rat.
    Aro J, Tokola H, Ronkainen VP, Koivisto E, Tenhunen O, Ilves M, Szokodi I, Ruskoaho H, Rysä J.
    Acta Physiol (Oxf); 2013 Mar 04; 207(3):470-84. PubMed ID: 23198998
    [Abstract] [Full Text] [Related]

  • 9. Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II.
    Seccia TM, Belloni AS, Kreutz R, Paul M, Nussdorfer GG, Pessina AC, Rossi GP.
    J Am Coll Cardiol; 2003 Feb 19; 41(4):666-73. PubMed ID: 12598081
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure.
    Iwanaga Y, Kihara Y, Inagaki K, Onozawa Y, Yoneda T, Kataoka K, Sasayama S.
    Circulation; 2001 Jul 31; 104(5):606-12. PubMed ID: 11479261
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T.
    Circulation; 1994 May 31; 89(5):2204-11. PubMed ID: 8181146
    [Abstract] [Full Text] [Related]

  • 12. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats.
    Oie E, Bjønerheim R, Grogaard HK, Kongshaug H, Smiseth OA, Attramadal H.
    Am J Physiol; 1998 Sep 31; 275(3):H868-77. PubMed ID: 9724291
    [Abstract] [Full Text] [Related]

  • 13. Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats.
    Zolk O, Quattek J, Seeland U, El-Armouche A, Eschenhagen T, Böhm M.
    Cardiovasc Res; 2002 Feb 01; 53(2):363-71. PubMed ID: 11827687
    [Abstract] [Full Text] [Related]

  • 14. Myocardial adrenergic dysfunction in rats with transgenic, human renin-dependent hypertension.
    Bohlender J, Hildenbrand U, Wagner KD, Günther J, Hempel P, Schlegel WP, Luft FC, Krause EG, Bartel S.
    J Hypertens; 2001 Aug 01; 19(8):1453-63. PubMed ID: 11518854
    [Abstract] [Full Text] [Related]

  • 15. Expression of human angiotensinogen-renin in rat: effects on transcription and heart function.
    Bartel S, Hoch B, Vetter D, Krause EG.
    Hypertension; 2002 Feb 01; 39(2):219-23. PubMed ID: 11847187
    [Abstract] [Full Text] [Related]

  • 16. Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
    Leskinen H, Vuolteenaho O, Ruskoaho H.
    Circ Res; 1997 Jan 01; 80(1):114-23. PubMed ID: 8978330
    [Abstract] [Full Text] [Related]

  • 17. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
    Kaddoura S, Firth JD, Boheler KR, Sugden PH, Poole-Wilson PA.
    Circulation; 1996 Jun 01; 93(11):2068-79. PubMed ID: 8640984
    [Abstract] [Full Text] [Related]

  • 18. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
    Karam H, Heudes D, Bruneval P, Gonzales MF, Löffler BM, Clozel M, Clozel JP.
    Hypertension; 1996 Sep 01; 28(3):379-85. PubMed ID: 8794820
    [Abstract] [Full Text] [Related]

  • 19. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG, Scheer C, Rupp H.
    J Hypertens Suppl; 1997 Dec 01; 15(6):S13-9. PubMed ID: 9493122
    [Abstract] [Full Text] [Related]

  • 20. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y, Oliver JR, Horowitz JD.
    Cardiovasc Res; 1998 Sep 01; 39(3):665-73. PubMed ID: 9861310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.